VMR Logo.png
Acute Migraine Drugs Market is expected to generate a revenue of USD 8.75 Billion by 2030, Globally, at 8.58% CAGR: Verified Market Research®
November 19, 2024 10:00 ET | Verified Market Research
Lewes, Delaware, Nov. 19, 2024 (GLOBE NEWSWIRE) -- The Global Acute Migraine Drugs Market Size is projected to grow at a CAGR of 8.58% from 2023 to 2030, according to a new report published by...
Color Logo.png
Veterinary Dermatology Drugs Market was valued at USD 7.63 billion in 2021 and projected to grow at a CAGR of 9.44% during the forecast period 2022-2029 : GreyViews
May 03, 2022 08:00 ET | GreyViews
Pune India, May 03, 2022 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and Middle East...
AMR Logo.png
U.S. Pain Management Drugs Market to Reach $39.35 Billion by 2027; Surge in Geriatric Population, and a Favourable Regulatory Scenario Drive the Growth in the U.S.: Says Allied Market Research
February 22, 2021 09:20 ET | Allied Market Research
Portland, OR, Feb. 22, 2021 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the U.S. Pain Management Drug Market accounted for $31.49 billion in 2019, and is estimated to...